Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24523N0258
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,196
Award facts
- Contract value 100% obligated
- $12,195.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Clarksburg, WV, USA
Award details come from SAM.gov/FPDS.
About this award
On January 4, 2023, the Department of Veterans Affairs (VA), Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg-30mg with a ceiling value of $12,195.72. The award was made under a firm fixed-price delivery order contract type with no set-aside designation utilized. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The contract was completed on January 9, 2023, with performance taking place in Clarksburg, West Virginia.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s broader engagement with the VA through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contractor maintains a substantial Indefinite Delivery Vehicle with the VA in the form of an $83.3 million Blanket Purchase Agreement for Jynarque through the National Acquisition Center, which runs through March 26, 2026. This delivery order represents a specific draw-down against that larger vehicle to fulfill VISN 5's pharmaceutical requirements, supporting the VA's mission of providing specialized pharmaceutical treatments to veterans across the United States.
Quick answers
Who was awarded contract 36C24523N0258?
36C24523N0258 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 4, 2023.
How much is contract 36C24523N0258 worth?
The government has obligated $12,196 on 36C24523N0258.
Is contract 36C24523N0258 an order under another contract?
Yes. 36C24523N0258 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0258 competed?
The extent of competition for 36C24523N0258 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award